Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. [electronic resource] by
- Zeller, J
- Poulsen, K T
- Sutton, J E
- Abdiche, Y N
- Collier, S
- Chopra, R
- Garcia, C A
- Pons, J
- Rosenthal, A
- Shelton, D L
Producer: 20090109
In:
British journal of pharmacology vol. 155
Availability: No items available.
|
|
|
19.
|
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. [electronic resource] by
- Pipas, J M
- Zaki, B I
- McGowan, M M
- Tsapakos, M J
- Ripple, G H
- Suriawinata, A A
- Tsongalis, G J
- Colacchio, T A
- Gordon, S R
- Sutton, J E
- Srivastava, A
- Smith, K D
- Gardner, T B
- Korc, M
- Davis, T H
- Preis, M
- Tarczewski, S M
- MacKenzie, T A
- Barth, R J
Producer: 20130429
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|